Explore how proteomics enables personalized medicine by improving patient stratification, treatment response, and diagnostics ...

Explore how proteomics transforms pharmaceutical R&D, from drug discovery to biomarker qualification and clinical development ...

n this study, 773 untreated breast cancer patients from all over China were collected and followed up for at least 5 years. We obtained clinical data from 773 cases, RNA sequencing data from 752 cases ...

Proteomics—a term first coined in the mid-1990s—refers to the study of the complete set of proteins expressed in a cell, tissue, or organism. In contrast to genomics and transcriptomics, proteomics is ...

This presentation will describe both common and specialized multiplex methods for RNA in situ hybridization (ISH) and immunohistochemical labeling of proteins (IHC). We initially used neuronal cell ...

Olink, part of Thermo Fisher Scientific, together with Psomagen, is excited to invite you to an expert panel discussion exploring how protein biomarkers are reshaping the future of oncology research.

Breast cancer remains one of the most prevalent and life-threatening forms of cancer, impacting millions worldwide. This malignancy's heterogeneity and complexity have long posed significant ...